HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 285/4/L808    most recent 00377.2002v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Vargaftig, B. B. Articles by Singer, M. Search for Related Content PubMed PubMed Citation Articles by Vargaftig, B. B. Articles by Singer, M.

Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR

Unité de Pharmacologie Cellulaire, Unité Associée Institut Pasteur-Institut National de la Santé et de la Recherche Médicale U485, Institut Pasteur, 75015 Paris, France

Submitted 5 November 2002 ; accepted in final form 28 May 2003

Antigen induces murine bronchial hyperreactivity (BHR), inflammation, mucus accumulation, and airway remodeling. To investigate whether leukotrienes (LT) mediate the effects of antigen [ovalbumin (Ova)], we studied 5-lipoxygenase (5-LO) expression in immunized BP2 mice and blocked LT synthesis with the 5-LO inhibitor zileuton or antagonized their effects with receptor antagonists [cysteinyl leukotriene (Cys-LT)-ra MK-571, LY-171883; LTB₄-ra PH-163]. Cys-LT content increased in the bronchoalveolar lavage fluid (BALF) as early as 15 min after the intratracheal instillation of Ova. Zileuton inhibited LT release in the BALF and eosinophil recruitment in the lungs, and dose dependently reduced BHR, mucus accumulation, and remodeling, as did the LT-ra. Thus LT, released just after antigen challenge, might constitute the first step in accounting for the effects of Ova. Because mucus accumulation is regulated via the EGF receptor (EGFR), which is also implicated in the effects of LT, we studied this pathway with AG-1478, an EGFR tyrosine kinase inhibitor given at 0.5, 4, and 20 mg/kg. AG-1478 inhibited BHR, inflammation, and lung remodeling induced by Ova or by molecules themselves generated by Ova, such as LT, IL-13, and monocyte chemoattractant protein-1, which promote identical effects, suggesting the involvement of the EGFR pathway in the asthma-like syndrome observed.

asthma; hyperreactivity; mucus; inflammation; remodeling; epidermal growth factor receptor

This article has been cited by other articles:

				T. R. Korfhagen, T. D. Le Cras, C. R. Davidson, S. M. Schmidt, M. Ikegami, J. A. Whitsett, and W. D. Hardie Rapamycin Prevents Transforming Growth Factor-{alpha}-Induced Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., November 1, 2009; 41(5): 562 - 572. [Abstract] [Full Text] [PDF]

				J.-A. Park and D. J. Tschumperlin Chronic Intermittent Mechanical Stress Increases MUC5AC Protein Expression Am. J. Respir. Cell Mol. Biol., October 1, 2009; 41(4): 459 - 466. [Abstract] [Full Text] [PDF]

				M. Tamaoka, M. Hassan, T. McGovern, D. Ramos-Barbon, T. Jo, Y. Yoshizawa, B. Tolloczko, Q. Hamid, and J. G. Martin The epidermal growth factor receptor mediates allergic airway remodelling in the rat Eur. Respir. J., November 1, 2008; 32(5): 1213 - 1223. [Abstract] [Full Text] [PDF]

				W. D. Hardie, C. Davidson, M. Ikegami, G. D. Leikauf, T. D. Le Cras, A. Prestridge, J. A. Whitsett, and T. R. Korfhagen EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-{alpha}-induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1217 - L1225. [Abstract] [Full Text] [PDF]

				A. P. L. de Oliveira, H. V. Domingos, G. Cavriani, A. S. Damazo, A. L. dos Santos Franco, S. M. Oliani, R. M. Oliveira-Filho, B. B. Vargaftig, and W. T. de Lima Cellular recruitment and cytokine generation in a rat model of allergic lung inflammation are differentially modulated by progesterone and estradiol Am J Physiol Cell Physiol, September 1, 2007; 293(3): C1120 - C1128. [Abstract] [Full Text] [PDF]

				E. L. Kramer, G. H. Deutsch, M. A. Sartor, W. D. Hardie, M. Ikegami, T. R. Korfhagen, and T. D. Le Cras Perinatal increases in TGF-{alpha} disrupt the saccular phase of lung morphogenesis and cause remodeling: microarray analysis Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L314 - L327. [Abstract] [Full Text] [PDF]

				C. Boxall, S. T. Holgate, and D. E. Davies The contribution of transforming growth factor-{beta} and epidermal growth factor signalling to airway remodelling in chronic asthma Eur. Respir. J., January 1, 2006; 27(1): 208 - 229. [Abstract] [Full Text] [PDF]

				L. D. Nelin, L. G. Chicoine, K. M. Reber, B. K. English, T. L. Young, and Y. Liu Cytokine-Induced Endothelial Arginase Expression Is Dependent on Epidermal Growth Factor Receptor Am. J. Respir. Cell Mol. Biol., October 1, 2005; 33(4): 394 - 401. [Abstract] [Full Text] [PDF]

				P-R Burgel and J A Nadel Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium Thorax, November 1, 2004; 59(11): 992 - 996. [Abstract] [Full Text] [PDF]